Our News

Our News

Find out about the latest events and advancements. This summarizes our press releases and latest events information.

2015

Benaroya Research Institute Welcomes Three New Board Members

Immunotherapy Research is Rebooting Seattle's Biotech Sector

Developing Disease-Modifying Therapies for Children with Type 1 Diabetes

2014

One in Every Three People with Type 1 Diabetes Produces Insulin Years Post-Diagnosis

Learn about Immunotherapy and BRI's Work in Seattle Business Magazine

Take a Look at Our Latest Newsletter -- Winter 2014!

Food Allergy Development Linked to Skin Exposure - New Study from Steven Ziegler, PhD

BRI to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question

BRI Receives $2.2 Million to Discover Biomarker that Triggers Allergies

Our New Fall Newsletter is Here!

Accelerator Corporation Secures $51.1 Million to Support Research

Immune Tolerance Network’s TrialShare Recognized for Using Data for Public Good

BRI Scientists Identify Drivers of Rheumatoid Arthritis

Food Allergy Consortium (SeaFAC) to Bring New Research to the Northwest

Benaroya Research Institute Evaluates Immunology Approach to Blocking Breast Cancer

Pages